Resource Center
Resource Center
In small northern Nigerian villages such as Bukka, 56 miles southeast of Kano City, health workers walk dusty paths under the searing heat of the tropical afternoon carrying lifesaving malaria drugs to children. Often, they work past sunset to ensure that they administer the drugs to as many eligible children as possible in a day....
Read more
In July 2014, CHAI and partners began work to implement a comprehensive Maternal and Newborn Health (MNH) program aimed at improving maternal and newborn health outcomes in the States of Kano, Katsina and Kaduna, northern Nigeria. A component of the program aims to strengthen emergency transport systems between rural communities and primary health care facilities...
Read more
The 2014 Annual Report highlights CHAI’s programmatic work around the world, thanks to our many dedicated partners and supporters.
Read more
Treating severe malaria with injectable artesunate instead of quinine can substantially reduce mortality. To increase uptake and improve health outcomes, CHAI supported ministries of health in six high-burden countries to overcome barriers to adoption. Learn more about CHAI’s work to increase update and reduce severe malaria mortality in this case study.
Read more
Access to better tolerated, more convenient regimens for HIV treatment promotes adherence and leads to better patient outcomes. CHAI is working to ensure affordable pricing and to address demand-side barriers to access. Increased uptake of optimal second-line regimens in Uganda and Nigeria has improved HIV treatment and will deliver US$6.5 million in savings by 2018....
Read more
CHAI and partners achieved a price reduction agreement for contraceptive implants that increased total implant distribution by 56 percent from 2012 to 2013 and will result in procurement savings of more than US$300 million over six years. Learn more about this agreement to expand access to contraceptive implants and improve women’s choice and well-being in...
Read more
Achieving universal access to HIV treatment requires using the resources available as efficiently as possible. To this end, CHAI supports 10 countries to conduct annual resource mapping. In Malawi, results have informed the allocation of US$300 million to high-impact interventions and increased national ownership of the HIV response. Learn more about CHAI’s work improving efficiency...
Read more
Viral hepatitis is a major public health problem throughout the world, killing more people every year than HIV.(i) Hepatitis C is a viral disease transmitted through infected bodily fluids and attacks the liver, slowly scarring the organ until the person acquires liver cancer or faces a number of other renal or hepatic conditions that diminish...
Read more
CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and consumables associated with diagnosing HIV in very young children. Learn more here.
Read more
CHAI’s Research and Development (R&D) Team works from a unique angle to support CHAI’s ambitions to improve patient outcomes in low- and middle-income countries. In particular, the team works to: 1. Identify, develop, validate, and transfer for manufacture and distribution better and less expensive drug formulations of existing HIV/AIDS, tuberculosis (TB), and malaria medicines; 2....
Read more